Guardant Health Inc (NAS:GH)
$ 29.54 0 (0%) Market Cap: 3.61 Bil Enterprise Value: 3.83 Bil PE Ratio: 0 PB Ratio: 52.66 GF Score: 70/100

Guardant Health Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 10, 2022 / 08:00PM GMT
Release Date Price: $92.41 (+5.21%)
Tycho W. Peterson
JPMorgan Chase & Co, Research Division - Senior Analyst

Good afternoon. I'm Tycho Peterson. It's my pleasure to introduce our next company this afternoon, which is Guardant. Just a quick reminder folks, if you have questions, you can submit them through the website.

And with that, I'll turn it over to Helmy.

Helmy Eltoukhy
Guardant Health, Inc. - Co-Founder, Co-CEO & Chairman

Thank you, Tycho, for the opportunity to present today at the conference. I'll begin with a brief overview detailing our Oncology division, and then will hand it over to AmirAli to give an update on screening and close out the presentation.

Please note our forward-looking statements. Almost a decade ago, we had a dream that liquid biopsy could be at the center of transforming cancer care across the entire continuum from early cancer screening to recurrence monitoring and to therapy prediction, bringing a powerful new precision oncology paradigm to clinical practice, and bringing to fruition the power of saving lives. During this time, we have

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot